Status:
UNKNOWN
Pulmonary Arterial Hypertension in Systemic Sclerosis
Lead Sponsor:
Fondazione IRCCS Policlinico San Matteo di Pavia
Conditions:
Systemic Sclerosis
Pulmonary Arterial Hypertension
Eligibility:
All Genders
18-90 years
Brief Summary
The purpose of this study is to evaluate the role of stress echocardiography, compared to standard echocardiography in the early identification of pulmonary arterial hypertension in systemic sclerosis...
Eligibility Criteria
Inclusion
- Patients with systemic sclerosis according to LeRoy criteria
Exclusion
- Pregnancy
- Significant valvular disease
- Low left ventricular function upon echocardiography (ejection fraction\<55%)
- History of atrial fibrillation, myocardial infarction, pulmonary thromboembolisms, neoplasia or severe hepatic disease.
Key Trial Info
Start Date :
December 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2020
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00617487
Start Date
December 1 2007
End Date
January 1 2020
Last Update
March 7 2018
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS Foundation Policlinico S. Matteo
Pavia, PV, Italy, 27100
2
IRCCS Policlinico S. Matteo
Pavia, PV, Italy, 27100